Henry Schein stock update, $35M Biolase private placement & more – 6 recent dental company key notes

Here are six recent news updates on dental device companies.

Advertisement

3M ESPE, the 3M’s dental division, received an award from the Dr. Edward B. Shils Entrepreneurial Fund for its support of the American Dental Association’s Give Kids a Smile program.

Biolase announced that certain investors, directors and employees agreed to purchase $35 million of unregistered shares of the company’s common stock, according to a StreetInsider.com report.

Angela Lalor, a senior vice president with Danaher, sold 8,450 shares of the company’s stock at an average of $79.45 per share, according to a Sleek Money report. The transaction was a total of $671,352.

Albert Sterkenburg, a vice president with DENTSPLY International, sold 2,000 shares of company stock for a transaction total of $101,020, according to a Ticker Report.

Last week, Henry Schein‘s share price reached a new 52-week high, according to a WKRB News & Analysis report. The company’s stock traded as high as $122.79.

Keller Laboratories introduced ClearDream, an oral appliance for the treatment of mild to moderate sleep apnea in adults.

If you have a question, issue or note to suggest on a dental device company or dental practice management company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.

More articles on dental issues:
8 practicing dentists on the biggest business & clinical trends in dentistry
Dr. Angela Canfield opens second dental office location
Henry M. Goldman School of Dental Medicine to go digital

Advertisement

Next Up in Uncategorized

  • Texas, Florida and Connecticut have seen the most DSO activity during the fourth quarter of 2025. Becker’s compiled a list…

  • Here are 11 key DSO updates from December: 1. Southlake, Texas-based Allied OMS added its first New Jersey practice. 2.…

  • Here are four recent updates on dental company CFOs: 1. Matthew Garth stepped down from his role as executive vice…

Advertisement

Comments are closed.